AD biomarkers in cognitive pre‐frailty: Preliminar results from the CompAS
The differences between the group of PPF without cognitive decline and the group with PRCPF seem to indicate that the presence of plasma AD markers is higher related to the cognitive status of the participants than to their functional status. Further investigation of this relationship would require regression models with CF status as the dependent variable and plasma AD biomarkers and functional markers as predictors.
Authors
- Juan Ansede‐Bermejo (ORCID: https://orcid.org/0000-0002-0576-6131)
- Sabela C. Mallo (ORCID: https://orcid.org/0000-0001-5750-2608)
- Onésimo Juncos‐Rabadán (ORCID: https://orcid.org/0000-0002-2485-1171)
- Fátima Fernández‐Feijoo (ORCID: https://orcid.org/0009-0005-0707-5448)
- Sonali Arora (ORCID: https://orcid.org/0000-0002-6661-3024)
- Ana Rodríguez‐Pérez (ORCID: https://orcid.org/0000-0001-6900-4171)
- David Facal
- Arturo X. Pereiro Rozas
Institutions
- Universidade de Santiago de Compostela (ES)
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Center for Research in Molecular Medicine and Chronic Diseases (ES)
- Centro de Investigación Biomédica en Red (ES)
- Instituto de Investigación Sanitaria de Santiago (ES)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70857_105031
- Primary Topic
- Frailty in Older Adults
- Type
- article
- Field-Weighted Citation Impact
- 0.00